We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Children’s National Medical Center to Investigate Diabetes Genetic Markers with OpenArray™ System

Read time: Less than a minute

BioTrove, Inc. has announced that researchers at the Children’s National Medical Center will use the BioTrove OpenArray™ SNP genotyping system to examine genes for diabetes-related traits, as well as to investigate genetic variants affecting skeletal muscle hypertrophy – the build-up of skeletal muscle tissue – with resistance training in multiple large populations.

“Research takes time and persistence to ensure accurate data, and when it comes to our young patients, we are seeking to speed up the clock while understanding how we can help. Children’s National is committed to finding innovative ways to address diseases affecting these young patients – including research into genetic indicators for certain conditions,” said Joseph Devany, Ph.D., assistant professor and head of the Genotyping Lab in the Research Center for Genetic Medicine at Children’s National Medical Center.

“Comparing thousands of samples across large populations would take several years with conventional methods. The high-throughput OpenArray system enables us to process samples in weeks instead of years, and its high accuracy helps conduct in-depth research without depleting our precious DNA samples,” said Eric Hoffman, Ph.D., Clark Professor of Pediatrics and director of the Research Center for Genetic Medicine at Children’s National.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.